日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

新辅助肿瘤内质粒IL-12电基因转移联合纳武利尤单抗治疗可手术切除的局部晚期黑色素瘤患者

Tarhini, Ahmad A; Eroglu, Zeynep; Eljilany, Islam; Zager, Jonathan S; Gonzalez, Ricardo J; Sarnaik, Amod A; Cruse, Carl Wayne; Khushalani, Nikhil I; De Aquino, Deanryan B; Abraham, Edith; Acevedo, Diana M; Richards, Allison; Schell, Michael J; Kalos, Denise; Chen, Pei-Ling; Messina, Jane L; Canton, David A; Sondak, Vernon K

First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0

免疫启动剂 IFx-Hu2.0 的首次人体 III/IV 期黑色素瘤临床试验

Markowitz, Joseph; Shamblott, Michael; Brohl, Andrew S; Sarnaik, Amod A; Eroglu, Zeynep; Khushalani, Nikhil I; Dukes, Christopher W; Chamizo, Alejandra; Bastawrous, Marina; Garcia, Edward T; Dehlawi, Ashraf; Chen, Pei-Ling; De Aquino, Deanryan B; Sondak, Vernon K; Tarhini, Ahmad A; Kim, Youngchul; Lawman, Patricia; Pilon-Thomas, Shari